Jeff Schindler
Jeff Schindler
Managing Editor
jschindler@advanstar.com
Jeff Schindler received his B.A. in English from the University at Buffalo and immediately began his career at a Long Island music bi-weekly magazine. He quickly moved on to become Associate Editor at Managing Automation magazine, where he covered manufacturing and technology. Jeff came to Pharmaceutical Executive after spending four years at Retailing Today, where he moved up the ranks from Desk Editor to Managing Editor. He has also consulted on special projects for License! Global magazine; startup lifestyle magazine Chagigah; advertising and web copywriting at Quinlan & Co.; as well as copy editing for Demand Studios. Jeff also recently earned a Certificate in Web design from Noble Desktop in New York.
He currently resides in Forest Hills, New York, with his wife, Robyn, and their Siamese cat, Hudson. Jeff is an avid outdoorsman who likes to spend his spare time in the country hiking, biking and skiing, and also plays saxophone and is a novice guitarist. He joined the magazine in July 2010.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
